Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions
Authors:
- Marla DubinskyMDMarla Dubinsky
- Alison Potts BleakmanABAlison Potts Bleakman
- Remo PanaccioneRPRemo Panaccione
- Toshifumi HibiTHToshifumi Hibi
- Stefan SchreiberSSStefan Schreiber
- David RubinDRDavid Rubin
- Axel DignassADAxel Dignass
- Isabel RedondoIRIsabel Redondo
- Theresa Hunter GibbleTGTheresa Hunter Gibble
- Cem KayhanCKCem Kayhan
- Simon TravisSTSimon Travis
Open Access
- 12 June 2023
- journal article
- review article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 118 (11) , 1940-1953
Abstract
Bowel urgency (BU), the sudden or immediate need for a bowel movement, is one of the most common and disruptive symptoms experienced by patients with ulcerative colitis (UC). Distinct from the separate symptom of increased stool frequency, BU has a substantial negative impact on quality of life and psychosocial functioning. Among patients with UC, BU is one of the top reasons for treatment dissatisfaction and one of the symptoms patients most want improved. Patients may not discuss BU often due to embarrassment, and healthcare providers may not address the symptom adequately due to the lack of awareness of validated tools and/or knowledge of the importance of assessing BU. The mechanism of BU in UC is multifactorial and includes inflammatory changes in the rectum that may be linked to hypersensitivity and reduced compliance of the rectum. Responsive and reliable patient-reported outcome measures of BU are needed to provide evidence of treatment benefits in clinical trials and facilitate communication in clinical practice. This review discusses the pathophysiology and clinical importance of BU in UC and its impact on the quality of life and psychosocial functioning. Patient-reported outcome measures developed to assess the severity of BU in UC are discussed alongside overviews of treatment options and clinical guidelines. Implications for the future management of UC from the perspective of BU are also explored.Keywords
Funding Information
- Eli Lilly and Company
This publication has 91 references indexed in Scilit:
- Current Management of Fecal IncontinenceThe Permanente Journal, 2013
- Assessing Health Status in Inflammatory Bowel Disease Using a Novel Single-Item Numeric Rating ScaleDigestive Diseases and Sciences, 2012
- Perception gaps between patients with ulcerative colitis and healthcare professionals: an online surveyBMC Gastroenterology, 2012
- Review article: defining remission in ulcerative colitisAlimentary Pharmacology & Therapeutics, 2011
- Biopsychosocial Model of Irritable Bowel SyndromeJournal of Neurogastroenterology and Motility, 2011
- Patient reported symptoms during an ulcerative colitis flare: A Qualitative Focus Group StudyEuropean Journal of Gastroenterology & Hepatology, 2009
- Identification of symptom domains in ulcerative colitis that occur frequently during flares and are responsive to changes in disease activityHealth and Quality of Life Outcomes, 2008
- The long‐term management of ulcerative colitisAlimentary Pharmacology & Therapeutics, 2004
- Guidelines for the management of inflammatory bowel disease in adultsGut, 2004
- A simple clinical colitis activity indexGut, 1998